Ethical challenges posed by clinical progress in AIDS

被引:21
作者
Bayer, R
Stryker, J
机构
[1] COLUMBIA UNIV,SCH PUBL HLTH,NEW YORK,NY
[2] UNIV CALIF SAN FRANCISCO,AIDS RES INST,CTR AIDS PREVENT STUDIES,SAN FRANCISCO,CA 94143
关键词
D O I
10.2105/AJPH.87.10.1599
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
[No abstract available]
引用
收藏
页码:1599 / 1602
页数:4
相关论文
共 28 条
[1]  
BAXTER D, 1997, NY TIMES 0306, pA23
[2]   DIRECTLY OBSERVED THERAPY FOR TUBERCULOSIS - HISTORY OF AN IDEA [J].
BAYER, R ;
WILKINSON, D .
LANCET, 1995, 345 (8964) :1545-1548
[3]   Public goods and fair prices - Balancing technological innovation with social well-being [J].
Brody, B .
HASTINGS CENTER REPORT, 1996, 26 (02) :5-11
[4]  
Carton B, 1996, WALL STREET J 1003, pA1
[5]  
CORCY L, 1996, NEW ENGL J MED, V335, P1142
[6]   HIV-1 protease inhibitors - A review for clinicians [J].
Deeks, SG ;
Smith, M ;
Holodniy, M ;
Kahn, JO .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (02) :145-153
[7]   HEALTH-INSURANCE COVERAGE AMONG PERSONS WITH AIDS - RESULTS FROM A MULTISTATE SURVEILLANCE PROJECT [J].
DIAZ, T ;
CHU, SY ;
CONTI, L ;
NAHLEN, BL ;
WHYTE, B ;
MOKOTOFF, E ;
SHIELDS, A ;
CHECKO, PJ ;
HERR, M ;
MUKHTAR, Q ;
RIETMEIJER, CA ;
LEVY, A ;
HERMANN, P ;
BUEHLER, JW .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1994, 84 (06) :1015-1018
[8]   Drug therapy - Antimicrobial-drug resistance [J].
Gold, HS ;
Moellering, RC .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (19) :1445-1453
[9]  
GOLDSTEIN A, 1996, WASHINGTON POST 0815, pA1
[10]  
GOODMAN E, 1997, BALTIMORE SUN 0318, pA9